Skip to content

Clinical trials

Completed Uterine Cervical Neoplasms trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Uterine Cervical Neoplasms Status: Completed Country / region: Australia Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20062
20083
20091
20111
20131
20174
20184
20206
20211
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed27

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Agenus Inc.2
GlaxoSmithKline2
Merck Sharp & Dohme LLC2
Queensland Centre for Gynaecological Cancer2
Akeso1
Antiva Biosciences1
Corvus Pharmaceuticals, Inc.1
EMD Serono Research & Development Institute, Inc.1
Exelixis1
Gynecologic Oncology Group1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Uterine Cervical Neoplasms27
Carcinoma, Non-Small-Cell Lung7
Ovarian Neoplasms7
Endometrial Neoplasms6
Squamous Cell Carcinoma of Head and Neck5
Triple Negative Breast Neoplasms5
Breast Neoplasms4
Colorectal Neoplasms4
Neoplasm Metastasis4
Neoplasms4

Trials

Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.